-transparent.png){kind=logo}
As prognostic factors of malignant lymphomas, many factors such as histopathology, clinical stage, surface phenotype, primary site, and serum LDH are listed. But when we analyse the data according to the period accumulated for a long time, big differences in survivals are always observed. This fact means that the therapeutic factors become a very important prognostic factors, and the importance of other prognostic factors are influenced by the therapeutic factors. The main subjects in the treatment of lymphomas are the improvement of therapeutic results and the reduction of the intensity of treatment of the patients in whom the cure are expected in high probability. In these situation, statistical analysis of the prognostic factors include therapeutic factor will contribute strongly to the improvement of treatment results.
A Oyama, and
K Morita, and
T Suchi, and
K Ota
January 1989,
Nouvelle revue francaise d'hematologie,
A Oyama, and
K Morita, and
T Suchi, and
K Ota
January 1987,
Acta haematologica,
A Oyama, and
K Morita, and
T Suchi, and
K Ota
July 2006,
Pakistan journal of pharmaceutical sciences,
A Oyama, and
K Morita, and
T Suchi, and
K Ota
March 1974,
Cancer,
A Oyama, and
K Morita, and
T Suchi, and
K Ota
August 2010,
Leukemia & lymphoma,
A Oyama, and
K Morita, and
T Suchi, and
K Ota
January 2010,
La Revue du praticien,
A Oyama, and
K Morita, and
T Suchi, and
K Ota
October 1993,
Seminars in oncology,
A Oyama, and
K Morita, and
T Suchi, and
K Ota
January 2000,
Sao Paulo medical journal = Revista paulista de medicina,
A Oyama, and
K Morita, and
T Suchi, and
K Ota
October 1988,
Sangre,
A Oyama, and
K Morita, and
T Suchi, and
K Ota
January 1993,
Pathologie-biologie,
